Is CBN legal in Luxembourg?

Formal status

CBN is classified as a Novel Food across the EU on the same basis as CBD - hemp extracts concentrated in cannabinoids fall within Regulation (EU) 2015/2283 - and no CBN ingestible holds Union list authorisation anywhere in the EU.

Luxembourg names cannabinol directly in its official guidance, listing delta-9-THC, CBD, CBG and CBN as the best known of the hemp cannabinoids. That naming is descriptive rather than prohibitive, but it removes any argument that Luxembourg has simply not considered CBN.

The prohibition itself is drafted around hemp extracts concentrated in cannabinoids as a class, with CBD given as an instance rather than as the boundary. A CBN-bearing extract is caught on exactly the same footing, and there is no separate authorisation route or reference value for CBN.

Do we sell here?

Yes, for now: Sleep spray, Sleep capsules.

Luxembourg is one of the few countries in Europe that names CBN at all in its official guidance on hemp. It does not treat CBN more permissively than CBD - the prohibition is written around hemp extracts concentrated in cannabinoids as a class, and CBN sits inside that wording just as CBD does.

So there is no ambiguity here we could lean on, and we are not pretending otherwise. We ship to Luxembourg on the same basis as our CBD position: Luxembourg's action in this area has been directed at products already on its market rather than at European sellers delivering to customers there.

We review this weekly.

Outlook

Because the Luxembourg prohibition attaches to cannabinoid-concentrated extracts as a class rather than to CBD by name, a CBN-forward reformulation gains nothing here, and an EU-level Novel Food authorisation for CBD alone would not carry CBN with it.

The specific thing to watch is analytical rather than legal. Luxembourg's 2021 campaign quantified CBD and THC by HPLC-DAD but did not report CBN separately. If a repeat campaign extends its analyte panel to CBN, that would be the first point at which CBN content becomes independently measurable against a Luxembourg finding.

Timeline

October 2021

Division de la Securite Alimentaire publishes fiche F-220 on Cannabis sativa L., setting out which hemp foods are permitted - industrial hemp seeds and seed-derived products, and aqueous infusions of leaves without flowering tops - and treating CBD extracts obtained from flowers or leaves as novel food requiring authorisation. It states that the 0.3 per cent THC figure is a reference value for the hemp plant in cultivation fields and does not apply to foodstuffs, where assessment must be made case by case against an acute reference dose of 1 microgram THC per kg body weight per day, and gives a worked example that two drops of 25 mg each of a CBD oil at 0.2 per cent THC exceed that dose. Version F-220-02, updated 3 July 2023.

Division de la Securite Alimentaire, Luxembourg (fiche F-220)

July 2022

Luxembourg publishes the results of a dedicated CBD control campaign: 10 products sampled from specialist hemp shops and from e-commerce on the Luxembourg market, of Luxembourgish, Dutch, French, Italian and German origin, analysed by HPLC-DAD at AGES in Vienna. All 10 were declared non-compliant because CBD is an unauthorised novel food, and 4 additionally exceeded the acute reference dose for THC. A Dutch 5 per cent CBD capsule product was compliant on THC but non-compliant on novel-food grounds.

Division de la Securite Alimentaire, Luxembourg

May 2026

Health Minister Martine Deprez confirms that the Direction de la Sante inspects CBD retailers in close collaboration with customs and the Grand Ducal Police, but that analyses of imported products are not systematic - customs test only at the request of a competent authority or where there is suspicion. The contemporaneous synthetic-cannabinoid case illustrates the reactive sequence: a drug-checking report on 3 March, laboratory confirmation of MDMB-Pinaca on 19 March, and a control visit only after that confirmation.

Le Quotidien, reporting the Minister of Health